Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
First report of Lasiodiplodia theobromae causing decline of blueberry (Vaccinium corymbosum L.) in the Czech Republic.

Plant disease

Pečenka J, Tekielska DA, Kacanova M, Peňázová E, Berraf-Teball A, Eichmeier A.
PMID: 32779538
Plant Dis. 2020 Aug 11; doi: 10.1094/PDIS-02-20-0329-PDN. Epub 2020 Aug 11.

Popularity of blueberries (Vaccinium corymbosum L.) has been rising worldwide, due to their nutritional bioactive compounds such as flavonoids, anthocyanins and polyphenols (Sinelli et al. 2008). These factors led to an increase of the demand for fresh blueberries in...

Cite
Pečenka J, Tekielska DA, Kacanova M, et al. First report of Lasiodiplodia theobromae causing decline of blueberry (Vaccinium corymbosum L.) in the Czech Republic. Plant Dis. 2020;doi: 10.1094/PDIS-02-20-0329-PDN.
Pečenka, J., Tekielska, D. A., Kacanova, M., Peňázová, E., Berraf-Teball, A., & Eichmeier, A. (2020). First report of Lasiodiplodia theobromae causing decline of blueberry (Vaccinium corymbosum L.) in the Czech Republic. Plant disease, . https://doi.org/10.1094/PDIS-02-20-0329-PDN
Pečenka, Jakub, et al. "First report of Lasiodiplodia theobromae causing decline of blueberry (Vaccinium corymbosum L.) in the Czech Republic." Plant disease vol. (2020). doi: https://doi.org/10.1094/PDIS-02-20-0329-PDN
Pečenka J, Tekielska DA, Kacanova M, Peňázová E, Berraf-Teball A, Eichmeier A. First report of Lasiodiplodia theobromae causing decline of blueberry (Vaccinium corymbosum L.) in the Czech Republic. Plant Dis. 2020 Aug 11; doi: 10.1094/PDIS-02-20-0329-PDN. Epub 2020 Aug 11. PMID: 32779538.
Copy Download .nbib Format: NLM
Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort.

The Prostate

Würnschimmel C, Kachanov M, Wenzel M, Mandel P, Karakiewicz PI, Maurer T, Steuber T, Tilki D, Graefen M, Budäus L.
PMID: 34110033
Prostate. 2021 Sep;81(12):849-856. doi: 10.1002/pros.24181. Epub 2021 Jun 10.

BACKGROUND: A trend towards inverse stage migration in prostate cancer (PCa) was reported. However, previous analyses did not take into account potential differences in sampling strategies (number of biopsy cores), which might have confounded these reports.MATERIAL AND METHODS: Within...

Cite
Würnschimmel C, Kachanov M, Wenzel M, et al. Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort. Prostate. 2021;81(12):849-856doi: 10.1002/pros.24181.
Würnschimmel, C., Kachanov, M., Wenzel, M., Mandel, P., Karakiewicz, P. I., Maurer, T., Steuber, T., Tilki, D., Graefen, M., & Budäus, L. (2021). Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort. The Prostate, 81(12), 849-856. https://doi.org/10.1002/pros.24181
Würnschimmel, Christoph, et al. "Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort." The Prostate vol. 81,12 (2021): 849-856. doi: https://doi.org/10.1002/pros.24181
Würnschimmel C, Kachanov M, Wenzel M, Mandel P, Karakiewicz PI, Maurer T, Steuber T, Tilki D, Graefen M, Budäus L. Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort. Prostate. 2021 Sep;81(12):849-856. doi: 10.1002/pros.24181. Epub 2021 Jun 10. PMID: 34110033.
Copy Download .nbib Format: NLM
MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction.

Pharmacogenomics and personalized medicine

Rytkin E, Mirzaev K, Bure I, Akmalova K, Abdullaev S, Kachanova A, Smirnov V, Grishina E, Lyakhova N, Aleshkovich E, Saribekian A, Andreev D, Shabunin A, Sychev D.
PMID: 34880651
Pharmgenomics Pers Med. 2021 Dec 02;14:1575-1582. doi: 10.2147/PGPM.S324612. eCollection 2021.

AIM: The aim of this study is to assess 6 micro-RNAs: miR-126, miR-223, miR-150, miR-29, miR-34, miR-142 as potential biomarkers for P2Y12- inhibitors resistance prediction.METHODS: Eighty patients with an acute coronary syndrome undergoing percutaneous coronary intervention treated in a...

Cite
Rytkin E, Mirzaev K, Bure I, et al. MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction. Pharmgenomics Pers Med. 2021;14:1575-1582doi: 10.2147/PGPM.S324612.
Rytkin, E., Mirzaev, K., Bure, I., Akmalova, K., Abdullaev, S., Kachanova, A., Smirnov, V., Grishina, E., Lyakhova, N., Aleshkovich, E., Saribekian, A., Andreev, D., Shabunin, A., & Sychev, D. (2021). MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction. Pharmacogenomics and personalized medicine, 141575-1582. https://doi.org/10.2147/PGPM.S324612
Rytkin, Eric, et al. "MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction." Pharmacogenomics and personalized medicine vol. 14 (2021): 1575-1582. doi: https://doi.org/10.2147/PGPM.S324612
Rytkin E, Mirzaev K, Bure I, Akmalova K, Abdullaev S, Kachanova A, Smirnov V, Grishina E, Lyakhova N, Aleshkovich E, Saribekian A, Andreev D, Shabunin A, Sychev D. MicroRNAs as Novel Biomarkers for P2Y12 - Inhibitors Resistance Prediction. Pharmgenomics Pers Med. 2021 Dec 02;14:1575-1582. doi: 10.2147/PGPM.S324612. eCollection 2021. PMID: 34880651; PMCID: PMC8648096.
Copy Download .nbib Format: NLM
CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes.

Drug metabolism and personalized therapy

Ivashchenko DV, Yudelevich DA, Buromskaya NI, Shimanov PV, Deitch RV, Akmalova KA, Kachanova AA, Dorina IV, Nastovich MI, Grishina EA, Savchenko LM, Shevchenko YS, Sychev DA.
PMID: 34388331
Drug Metab Pers Ther. 2021 Aug 12; doi: 10.1515/dmdi-2021-0124. Epub 2021 Aug 12.

OBJECTIVES: To identify possible associations of METHODS: We examined the associations of pharmacogenetic factors with the efficacy and safety of antipsychotics in 101 adolescents with acute psychotic episodes. The diagnosis on admission was "Brief psychotic disorder" (F23.0-23.9 by ICD-10)....

Cite
Ivashchenko DV, Yudelevich DA, Buromskaya NI, et al. CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes. Drug Metab Pers Ther. 2021;doi: 10.1515/dmdi-2021-0124.
Ivashchenko, D. V., Yudelevich, D. A., Buromskaya, N. I., Shimanov, P. V., Deitch, R. V., Akmalova, K. A., Kachanova, A. A., Dorina, I. V., Nastovich, M. I., Grishina, E. A., Savchenko, L. M., Shevchenko, Y. S., & Sychev, D. A. (2021). CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes. Drug metabolism and personalized therapy, . https://doi.org/10.1515/dmdi-2021-0124
Ivashchenko, Dmitriy V, et al. "CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes." Drug metabolism and personalized therapy vol. (2021). doi: https://doi.org/10.1515/dmdi-2021-0124
Ivashchenko DV, Yudelevich DA, Buromskaya NI, Shimanov PV, Deitch RV, Akmalova KA, Kachanova AA, Dorina IV, Nastovich MI, Grishina EA, Savchenko LM, Shevchenko YS, Sychev DA. CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes. Drug Metab Pers Ther. 2021 Aug 12; doi: 10.1515/dmdi-2021-0124. Epub 2021 Aug 12. PMID: 34388331.
Copy Download .nbib Format: NLM
Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S).

Scientific reports

Karagiotis T, Witt JH, Jankowski T, Mendrek M, Wagner C, Schuette A, Liakos N, Rachubinski P, Urbanova K, Oelke M, Kachanov M, Leyh-Bannurah SR.
PMID: 34997130
Sci Rep. 2022 Jan 07;12(1):244. doi: 10.1038/s41598-021-04289-2.

The quality of life (QoL) of men with optimal outcomes after robot-assisted radical prostatectomy (RARP) is largely unexplored. Thus we assessed meaningful changes of QoL measured with the EORTC QLQ-C30 24 months after RARP according to postsurgical Cancer of...

Cite
Karagiotis T, Witt JH, Jankowski T, et al. Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S). Sci Rep. 2022;12(1):244doi: 10.1038/s41598-021-04289-2.
Karagiotis, T., Witt, J. H., Jankowski, T., Mendrek, M., Wagner, C., Schuette, A., Liakos, N., Rachubinski, P., Urbanova, K., Oelke, M., Kachanov, M., & Leyh-Bannurah, S. R. (2022). Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S). Scientific reports, 12(1), 244. https://doi.org/10.1038/s41598-021-04289-2
Karagiotis, Theodoros, et al. "Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S)." Scientific reports vol. 12,1 (2022): 244. doi: https://doi.org/10.1038/s41598-021-04289-2
Karagiotis T, Witt JH, Jankowski T, Mendrek M, Wagner C, Schuette A, Liakos N, Rachubinski P, Urbanova K, Oelke M, Kachanov M, Leyh-Bannurah SR. Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S). Sci Rep. 2022 Jan 07;12(1):244. doi: 10.1038/s41598-021-04289-2. PMID: 34997130.
Copy Download .nbib Format: NLM
Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S).

Scientific reports

Karagiotis T, Witt JH, Jankowski T, Mendrek M, Wagner C, Schuette A, Liakos N, Rachubinski P, Urbanova K, Oelke M, Kachanov M, Leyh-Bannurah SR.
PMID: 34997130
Sci Rep. 2022 Jan 07;12(1):244. doi: 10.1038/s41598-021-04289-2.

The quality of life (QoL) of men with optimal outcomes after robot-assisted radical prostatectomy (RARP) is largely unexplored. Thus we assessed meaningful changes of QoL measured with the EORTC QLQ-C30 24 months after RARP according to postsurgical Cancer of...

Cite
Karagiotis T, Witt JH, Jankowski T, et al. Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S). Sci Rep. 2022;12(1):244doi: 10.1038/s41598-021-04289-2.
Karagiotis, T., Witt, J. H., Jankowski, T., Mendrek, M., Wagner, C., Schuette, A., Liakos, N., Rachubinski, P., Urbanova, K., Oelke, M., Kachanov, M., & Leyh-Bannurah, S. R. (2022). Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S). Scientific reports, 12(1), 244. https://doi.org/10.1038/s41598-021-04289-2
Karagiotis, Theodoros, et al. "Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S)." Scientific reports vol. 12,1 (2022): 244. doi: https://doi.org/10.1038/s41598-021-04289-2
Karagiotis T, Witt JH, Jankowski T, Mendrek M, Wagner C, Schuette A, Liakos N, Rachubinski P, Urbanova K, Oelke M, Kachanov M, Leyh-Bannurah SR. Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S). Sci Rep. 2022 Jan 07;12(1):244. doi: 10.1038/s41598-021-04289-2. PMID: 34997130; PMCID: PMC8742105.
Copy Download .nbib Format: NLM
Optimizing Combined Magnetic Resonance Imaging-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric Magnetic Resonance Imaging-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric Magnetic Resonance Imaging-Suspect Lesions.

The Journal of urology

Kachanov M, Leyh-Bannurah SR, Roberts MJ, Sauer M, Beyersdorff D, Boiko S, Maurer T, Steuber T, Graefen M, Budäus L.
PMID: 34555925
J Urol. 2021 Sep 24;101097JU0000000000002248. doi: 10.1097/JU.0000000000002248. Epub 2021 Sep 24.

PURPOSE: We assessed whether sampling of the transitional zone can be spared in patients with exclusively peripheral prostate cancer (PCa)-suspicious multiparametric magnetic resonance imaging (mpMRI) lesions who undergo combined mpMRI targeted (TBx) and systematic prostate biopsies (SBx).MATERIALS AND METHODS:...

Cite
Kachanov M, Leyh-Bannurah SR, Roberts MJ, et al. Optimizing Combined Magnetic Resonance Imaging-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric Magnetic Resonance Imaging-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric Magnetic Resonance Imaging-Suspect Lesions. J Urol. 2021;101097JU0000000000002248doi: 10.1097/JU.0000000000002248.
Kachanov, M., Leyh-Bannurah, S. R., Roberts, M. J., Sauer, M., Beyersdorff, D., Boiko, S., Maurer, T., Steuber, T., Graefen, M., & Budäus, L. (2021). Optimizing Combined Magnetic Resonance Imaging-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric Magnetic Resonance Imaging-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric Magnetic Resonance Imaging-Suspect Lesions. The Journal of urology, 101097JU0000000000002248. https://doi.org/10.1097/JU.0000000000002248
Kachanov, Mykyta, et al. "Optimizing Combined Magnetic Resonance Imaging-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric Magnetic Resonance Imaging-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric Magnetic Resonance Imaging-Suspect Lesions." The Journal of urology vol. (2021): 101097JU0000000000002248. doi: https://doi.org/10.1097/JU.0000000000002248
Kachanov M, Leyh-Bannurah SR, Roberts MJ, Sauer M, Beyersdorff D, Boiko S, Maurer T, Steuber T, Graefen M, Budäus L. Optimizing Combined Magnetic Resonance Imaging-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric Magnetic Resonance Imaging-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric Magnetic Resonance Imaging-Suspect Lesions. J Urol. 2021 Sep 24;101097JU0000000000002248. doi: 10.1097/JU.0000000000002248. Epub 2021 Sep 24. PMID: 34555925.
Copy Download .nbib Format: NLM
Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions.

The Journal of urology

Kachanov M, Leyh-Bannurah SR, Roberts MJ, Sauer M, Beyersdorff D, Boiko S, Maurer T, Steuber T, Graefen M, Budäus L.
PMID: 34555925
J Urol. 2022 Feb;207(2):333-340. doi: 10.1097/JU.0000000000002248. Epub 2021 Sep 24.

PURPOSE: We assessed whether sampling of the transitional zone can be spared in patients with exclusively peripheral prostate cancer (PCa)-suspicious multiparametric magnetic resonance imaging (mpMRI) lesions who undergo combined mpMRI targeted (TBx) and systematic prostate biopsies (SBx).MATERIALS AND METHODS:...

Cite
Kachanov M, Leyh-Bannurah SR, Roberts MJ, et al. Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions. J Urol. 2021;207(2):333-340doi: 10.1097/JU.0000000000002248.
Kachanov, M., Leyh-Bannurah, S. R., Roberts, M. J., Sauer, M., Beyersdorff, D., Boiko, S., Maurer, T., Steuber, T., Graefen, M., & Budäus, L. (2022). Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions. The Journal of urology, 207(2), 333-340. https://doi.org/10.1097/JU.0000000000002248
Kachanov, Mykyta, et al. "Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions." The Journal of urology vol. 207,2 (2022): 333-340. doi: https://doi.org/10.1097/JU.0000000000002248
Kachanov M, Leyh-Bannurah SR, Roberts MJ, Sauer M, Beyersdorff D, Boiko S, Maurer T, Steuber T, Graefen M, Budäus L. Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions. J Urol. 2022 Feb;207(2):333-340. doi: 10.1097/JU.0000000000002248. Epub 2021 Sep 24. PMID: 34555925.
Copy Download .nbib Format: NLM
Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions.

The Journal of urology

Kachanov M, Leyh-Bannurah SR, Roberts MJ, Sauer M, Beyersdorff D, Boiko S, Maurer T, Steuber T, Graefen M, Budäus L.
PMID: 34555925
J Urol. 2022 Feb;207(2):333-340. doi: 10.1097/JU.0000000000002248. Epub 2021 Sep 24.

PURPOSE: We assessed whether sampling of the transitional zone can be spared in patients with exclusively peripheral prostate cancer (PCa)-suspicious multiparametric magnetic resonance imaging (mpMRI) lesions who undergo combined mpMRI targeted (TBx) and systematic prostate biopsies (SBx).MATERIALS AND METHODS:...

Cite
Kachanov M, Leyh-Bannurah SR, Roberts MJ, et al. Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions. J Urol. 2021;207(2):333-340doi: 10.1097/JU.0000000000002248.
Kachanov, M., Leyh-Bannurah, S. R., Roberts, M. J., Sauer, M., Beyersdorff, D., Boiko, S., Maurer, T., Steuber, T., Graefen, M., & Budäus, L. (2022). Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions. The Journal of urology, 207(2), 333-340. https://doi.org/10.1097/JU.0000000000002248
Kachanov, Mykyta, et al. "Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions." The Journal of urology vol. 207,2 (2022): 333-340. doi: https://doi.org/10.1097/JU.0000000000002248
Kachanov M, Leyh-Bannurah SR, Roberts MJ, Sauer M, Beyersdorff D, Boiko S, Maurer T, Steuber T, Graefen M, Budäus L. Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions. J Urol. 2022 Feb;207(2):333-340. doi: 10.1097/JU.0000000000002248. Epub 2021 Sep 24. PMID: 34555925.
Copy Download .nbib Format: NLM
The effect of heated floor on the outcome coccidiosis in broilers.

Journal of parasitic diseases : official organ of the Indian Society for Parasitology

Kachanova EO, Safiullin RT.
PMID: 32508421
J Parasit Dis. 2020 Jun;44(2):447-452. doi: 10.1007/s12639-020-01191-y. Epub 2020 Jan 13.

Coccidiosis is the most common protozoan disease in poultry farms around the world and causes serious economic losses. The purpose of this study was to determine the effect floor heating on the outcome

Cite
Kachanova EO, Safiullin RT. The effect of heated floor on the outcome coccidiosis in broilers. J Parasit Dis. 2020;44(2):447-452doi: 10.1007/s12639-020-01191-y.
Kachanova, E. O., & Safiullin, R. T. (2020). The effect of heated floor on the outcome coccidiosis in broilers. Journal of parasitic diseases : official organ of the Indian Society for Parasitology, 44(2), 447-452. https://doi.org/10.1007/s12639-020-01191-y
Kachanova, Ekaterina Olegovna, and Safiullin, Rinat Tuktarovich. "The effect of heated floor on the outcome coccidiosis in broilers." Journal of parasitic diseases : official organ of the Indian Society for Parasitology vol. 44,2 (2020): 447-452. doi: https://doi.org/10.1007/s12639-020-01191-y
Kachanova EO, Safiullin RT. The effect of heated floor on the outcome coccidiosis in broilers. J Parasit Dis. 2020 Jun;44(2):447-452. doi: 10.1007/s12639-020-01191-y. Epub 2020 Jan 13. PMID: 32508421; PMCID: PMC7244672.
Copy Download .nbib Format: NLM
Adipocytokines in Graves' orbitopathy and the effect of high-dose corticosteroids.

Adipocyte

Schovanek J, Krupka M, Cibickova L, Karhanova M, Reddy S, Kucerova V, Frysak Z, Karasek D.
PMID: 34602013
Adipocyte. 2021 Dec;10(1):456-462. doi: 10.1080/21623945.2021.1980258.

Graves' orbitopathy (GO) is a serious, progressive eye condition seen in patients with autoimmune thyroid disease. GO is characterized by inflammation and swelling of soft orbital tissues. Adipose tissue produces cytokine mediators called adipokines. The present study focuses on...

Cite
Schovanek J, Krupka M, Cibickova L, et al. Adipocytokines in Graves' orbitopathy and the effect of high-dose corticosteroids. Adipocyte. 2021;10(1):456-462doi: 10.1080/21623945.2021.1980258.
Schovanek, J., Krupka, M., Cibickova, L., Karhanova, M., Reddy, S., Kucerova, V., Frysak, Z., & Karasek, D. (2021). Adipocytokines in Graves' orbitopathy and the effect of high-dose corticosteroids. Adipocyte, 10(1), 456-462. https://doi.org/10.1080/21623945.2021.1980258
Schovanek, Jan, et al. "Adipocytokines in Graves' orbitopathy and the effect of high-dose corticosteroids." Adipocyte vol. 10,1 (2021): 456-462. doi: https://doi.org/10.1080/21623945.2021.1980258
Schovanek J, Krupka M, Cibickova L, Karhanova M, Reddy S, Kucerova V, Frysak Z, Karasek D. Adipocytokines in Graves' orbitopathy and the effect of high-dose corticosteroids. Adipocyte. 2021 Dec;10(1):456-462. doi: 10.1080/21623945.2021.1980258. PMID: 34602013; PMCID: PMC8496533.
Copy Download .nbib Format: NLM
Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S).

Scientific reports

Karagiotis T, Witt JH, Jankowski T, Mendrek M, Wagner C, Schuette A, Liakos N, Rachubinski P, Urbanova K, Oelke M, Kachanov M, Leyh-Bannurah SR.
PMID: 34997130
Sci Rep. 2022 Jan 07;12(1):244. doi: 10.1038/s41598-021-04289-2.

The quality of life (QoL) of men with optimal outcomes after robot-assisted radical prostatectomy (RARP) is largely unexplored. Thus we assessed meaningful changes of QoL measured with the EORTC QLQ-C30 24 months after RARP according to postsurgical Cancer of...

Cite
Karagiotis T, Witt JH, Jankowski T, et al. Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S). Sci Rep. 2022;12(1):244doi: 10.1038/s41598-021-04289-2.
Karagiotis, T., Witt, J. H., Jankowski, T., Mendrek, M., Wagner, C., Schuette, A., Liakos, N., Rachubinski, P., Urbanova, K., Oelke, M., Kachanov, M., & Leyh-Bannurah, S. R. (2022). Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S). Scientific reports, 12(1), 244. https://doi.org/10.1038/s41598-021-04289-2
Karagiotis, Theodoros, et al. "Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S)." Scientific reports vol. 12,1 (2022): 244. doi: https://doi.org/10.1038/s41598-021-04289-2
Karagiotis T, Witt JH, Jankowski T, Mendrek M, Wagner C, Schuette A, Liakos N, Rachubinski P, Urbanova K, Oelke M, Kachanov M, Leyh-Bannurah SR. Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S). Sci Rep. 2022 Jan 07;12(1):244. doi: 10.1038/s41598-021-04289-2. PMID: 34997130.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries